1. REVERSAL AGENTS FOR NOACS: Do WE NEED THEM in THE EP LAB?

6. ESC Guidelines: Anticoagulation Use in AF

8. Checklist for Anticoagulation Prior to Ablation Procedure

10. Idarucizumab Is Now Approved

11. Idarucizumab Has Demonstrated Fast and Reliable Reversal of Dabigatran as Measured by dTT Levels

15. EHRA Scientific Statement: What Is the Recommended Periprocedural NOAC Use During AF Ablation?

19. Research Continues…Uninterrupted Use of NOACs During Ablation

20. Management of Bleeding in the EP Lab

21. Management of Cardiac Tamponade During Ablation for AF: Leipzig Heart Institute

22. Restarting the NOAC After a Bleeding Event Following Ablation

24. ESC Guidelines for AF: Cardioversion, TEE, and Anticoagulation

25. Conclusions

26. Conclusions (cont)

27. Abbreviations

28. Abbreviations (cont)